Cargando…

Staphylococcus aureus Bacteremia in Children: The Effect of Methicillin Resistance

BACKGROUND: Staphylococcus aureus bacteremia can occur in children in association with skin/soft tissue, musculoskeletal, respiratory, and endovascular infections. The effect of methicillin resistance on clinical outcomes in children with S. aureus bacteremia has not been clearly described. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamdy, Rana F, Dona, Daniele, Gerber, Jeffrey S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630777/ http://dx.doi.org/10.1093/ofid/ofx163.1826

Ejemplares similares

1511. Effect of Discharge Antibiotic Route on Clinical Outcomes in Children with Methicillin-Resistant Staphylococcus aureus (MRSA) Osteomyelitis with Bacteremia
por: Olson, Jared, et al.
Publicado: (2019)

Treatment of Staphylococcus aureus Bacteremia in Children: Is Intravenous Therapy Always Needed?
por: Dona, Daniele, et al.
Publicado: (2017)

Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017)

Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Choo, Eun Ju, et al.
Publicado: (2016)

850. External Validation of the Methicillin-Resistant Staphylococcus aureus Bacteremia Score
por: Boyle, Ellen, et al.
Publicado: (2020)

672 Staphylococcus aureus Bacteremia in Hospitalized Children
por: Klieger, Sarah B., et al.
Publicado: (2014)

2129. When Is Methicillin-resistant Staphylococcus aureus not Methicillin-resistant Staphylococcus aureus?
por: Gitman, Melissa R, et al.
Publicado: (2019)

1514. Factors Associated with an Infectious Diseases Consultation for Pediatric Staphylococcus aureus Bacteremia
por: Curley, Tara E, et al.
Publicado: (2019)

711. Molecular Epidemiology of Daptomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
por: Sundaram, Ayesha, et al.
Publicado: (2018)

1373. Racial Disparities in Clinical Characteristics and Outcomes for Methicillin Susceptible and Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Mohnasky, Michael C, et al.
Publicado: (2021)

187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021)

1227. Development of a Clinical Prediction Model for Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Jorgensen, Sarah, et al.
Publicado: (2018)

1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Fox, Matthew, et al.
Publicado: (2018)

1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Caniff, Kaylee E, et al.
Publicado: (2023)

136. Factors Associated with Reduced Vancomycin Susceptibility in Pediatric Staphylococcus aureus Bacteremia
por: Ericson, Jessica E, et al.
Publicado: (2019)

Attributable mortality in critically ill patients with bacteremia involving methicillin susceptible (MSSA) and methicillin resistant Staphylococcus aureus (MRSA)
por: Blot, S, et al.
Publicado: (2001)

Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia
por: Lachant, Daniel J., et al.
Publicado: (2013)

1804. Impact of Susceptibility Testing Method on Antibiotic Selection for Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia
por: Bhatt, Mahesh, et al.
Publicado: (2018)

190. Outcomes of Early Ceftaroline-based Combination Therapy for Methicillin-resistant Staphylococcus aureus Bacteremia
por: Dolan, Mackenzie, et al.
Publicado: (2021)

282. Epidemiological Evaluation of Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia: A Comprehensive Cancer Center’s 10-Year Experience
por: Ford, Charles R, et al.
Publicado: (2020)

947. Evaluating the Outcomes of Infectious Diseases Consultation on methicillin susceptible Staphylococcus aureus Bacteremia
por: Viteri, Alina, et al.
Publicado: (2022)

395 Impact of vancomycin pharmacokinetic/pharmacodynamic data on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children
por: Yoo, Reenar, et al.
Publicado: (2014)

554. The Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus Causing Bacteremia in Hiroshima, Japan During 2008–2017
por: Kitagawa, Hiroki, et al.
Publicado: (2019)

266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Mohamed, Adham, et al.
Publicado: (2020)

1216. Cost-Effectiveness of Penicillin Skin Allergy Testing in Methicillin-Sensitive Staphylococcus aureus (MSSA) Bacteremia
por: Meninger, Stephen, et al.
Publicado: (2018)

1067. Comparative Effectiveness of Nafcillin or Oxacillin, Cefazolin, and Piperacillin/Tazobactam in Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Beganovic, Maya, et al.
Publicado: (2018)

276. Comparison of Ceftaroline in Combination with Either Vancomycin or Daptomycin for the Treatment of Methicillin-resistant Staphylococcus aureus Bacteremia
por: Welch, Stephanie N, et al.
Publicado: (2020)

97. The Utilization of Echocardiography in Children with Staphylococcus aureus Bacteremia
por: Bui, Richard, et al.
Publicado: (2023)

Association of methicillin resistance with mortality of hospital-acquired Staphylococcus aureus bacteremia
por: Aratani, Tomonori, et al.
Publicado: (2021)

Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Host, Pathogen, and Treatment
por: Parsons, Joshua B., et al.
Publicado: (2023)

1061. Comparison of the Acute Physiology and Chronic Health Evaluation (APACHE) II Score and the Pitt Bacteremia Score to Predict Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Jorgensen, Sarah, et al.
Publicado: (2018)

2559. Incidence and Clinical Impact of Discordant Genotypic and Phenotypic Categorization of Methicillin Susceptibility in Staphylococcus aureus Bacteremia
por: Gulliver, Jessica, et al.
Publicado: (2018)

217. Combination Salvage Therapy with Cefazolin Plus Ertapenem for Refractory Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Rose Ulloa, Erlinda, et al.
Publicado: (2019)

248. Evaluation of Continuous versus Intermittent Infusion of Nafcillin in the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Williamson, Julie E, et al.
Publicado: (2023)

559. Two Different Beasts: Comparing Epidemiology of Healthcare-Associated vs. Community-Acquired Methicillin-Resistant Staphylococcus aureus Bacteremia
por: McLaughlin, Luke, et al.
Publicado: (2019)

637. Whole-Genome Sequencing (WGS) of Isolates from Resolving (RB) and Persistent (PB) Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Sharma-Kuinkel, Batu K, et al.
Publicado: (2019)

Resolution of Staphylococcus aureus (methicillin-resistant Staphylococcus aureus) osteomyelitis by oral linezolid
por: Gomes, PN, et al.
Publicado: (2003)

1788. Cost-Effectiveness of Penicillin Skin Testing Among Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy
por: Vaisman, Alon, et al.
Publicado: (2018)

Impact of Methicillin-Resistance on Mortality in Children and Neonates with Staphylococcus aureus Bacteremia: A Meta-analysis
por: Park, Dong Ah, et al.
Publicado: (2013)

Effects of Iclaprim and Trimethoprim on Exotoxin Production by Methicillin-resistant Staphylococcus aureus
por: Bryant, Amy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qufqbfrnasgl699ghljmd62mnp